Select Publications

Conference Papers

Al-Faraidy N; Deodhare N; Naert K; Joshua A; Hogg D; Butler M; Kamel-Reid S; Alhabeeb A; Ghazarian D, 2015, 'Molecular Profiling of Common Melanoma Mutations A Large Cohort Study', in LABORATORY INVESTIGATION, NATURE PUBLISHING GROUP, MA, Boston, pp. 510A - 511A, presented at 104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, MA, Boston, 21 March 2015 - 27 March 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000348948003549&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Abi-Saab T; Bavi P; Jiang J; Siva M; Chadwick D; Joshua A; Roehrl M, 2015, 'The Effect of Time Between Patient Death and Tissue Collection on RNA Integrity of Metastatic Tumors', in LABORATORY INVESTIGATION, NATURE PUBLISHING GROUP, MA, Boston, pp. 4A - 4A, presented at 104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, MA, Boston, 21 March 2015 - 27 March 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000348948000002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leibowitz-Amit R; Pintille M; Laird AD; Aftab DT; Berger R; Chi KN; Joshua AM, 2015, 'Association of changes in biomarkers with treatment with cabozantinib (Cabo) in metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the 100mg nonrandomized expansion cohort of a randomized discontinuation trials', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, presented at Genitourinary Cancers Symposium, FL, Orlando, 26 February 2015 - 28 February 2015, http://dx.doi.org/10.1200/jco.2015.33.7_suppl.196

Hotte SJ; Joshua AM; Torri V; Macfarlane RJ; Basappa NS; Powers J; Winquist E; Mukherjee S; Gregg RW; Kollmannsberger CK; Finch DL; Xu H; Hausman DF; Seymour L; Eisenhauer EA; Chi KN, 2015, 'IND 205B: A phase II study of the PI3K inhibitor PX-866 and continued abiraterone/prednisone in patients with recurrent or metastatic castration resistant prostate cancer (CRPC) with PSA progression on abiraterone/prednisone.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, presented at Genitourinary Cancers Symposium, FL, Orlando, 26 February 2015 - 28 February 2015, http://dx.doi.org/10.1200/jco.2015.33.7_suppl.279

Bavi P; Siva M; Butany J; Joshua A; Roehrl M, 2015, 'A Cancer Center's Large-Scale Rapid (Warm) Autopsy Program: Unique Insights Into Tumor Kinetics and Biology', in MODERN PATHOLOGY, SPRINGERNATURE, pp. 4A - 4A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349502200004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Al-Faraidy N; Deodhare N; Naert K; Joshua A; Hogg D; Butler M; Kamel-Reid S; Alhabeeb A; Ghazarian D, 2015, 'Molecular Profiling of Common Melanoma Mutations - A Large Cohort Study', in MODERN PATHOLOGY, SPRINGERNATURE, pp. 510A - 511A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349502203246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Abi-Saab T; Bavi P; Jiang J; Siva M; Chadwick D; Joshua A; Roehrl M, 2015, 'The Effect of Time Between Patient Death and Tissue Collection on RNA Integrity of Metastatic Tumors', in MODERN PATHOLOGY, SPRINGERNATURE, pp. 4A - 4A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349502200002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Daud A; Hamid O; Robert C; Hodi FS; Wolchok JD; Hwu WJ; Weber JS; Kefford R; Hersey P; Joshua AM; Joseph R; Gangadhar TC; Dronca R; Patnaik A; Zarour H; Gerigich K; Lunceford J; Emacipator K; Dolled-Filhart M; Li X; Kang P; Ebbinghaus S; Ribas A, 2014, 'Relationship between programmed death ligand 1 (PD-L1) expression and clinical outcome in patients (pts) with melanoma (MEL) treated with pembrolizumab (pembro; MK-3475)', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SPAIN, European Org Res & Treatment Canc, Barcelona, pp. 48 - 49, presented at 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, SPAIN, European Org Res & Treatment Canc, Barcelona, 18 November 2014 - 21 November 2014, http://dx.doi.org/10.1016/S0959-8049(14)70266-7

Khoja L; Kurtz G; Zadeh G; Laperriere N; Menard C; Millar B-A; Bernstein M; Kongkham P; Joshua A; Hogg D; Butler M; Chung C, 2014, 'INCREASED ACUTE RADIATION EFFECT (ARE) WITH IPILUMUMAB AND RADIOSURGERY IN PATIENTS WITH MELANOMA BRAIN METASTASES', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, http://dx.doi.org/10.1093/neuonc/nou240.16

Robert C; Joshua AM; Weber JS; Ribas A; Hodi FS; Kefford RF; Daud A; Wolchok JD; Hwu W-J; Gangadhar TC; Patnaik A; Hersey P; Dronca R; Zarour H; Ge Y; Lindia JA; Giannotti M; Ebbinghaus S; Kang SP; Hamid O, 2014, 'PEMBROLIZUMAB (PEMBRO; MK-3475) FOR ADVANCED MELANOMA (MEL): RANDOMIZED COMPARISON OF TWO DOSING SCHEDULES', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SPAIN, Madrid, presented at 39th ESMO Congress (ESMO), SPAIN, Madrid, 26 September 2014 - 30 September 2014, http://dx.doi.org/10.1093/annonc/mdu438.42

Kefford R; Hamid O; Robert C; Ribas A; Wolchock JD; Hodi FS; Joshua AM; Hwu W-J; Gangadhar TC; Patnaik A; Hersey P; Weber J; Joseph R; Gergich K; Li X; Chun P; Ebbinghaus S; Kang SP; Daud A, 2014, 'Randomized comparison of two doses of the anti-programmed death-1 monoclonal antibody MK-3475 for ipilimumab (IPI)-refractory and IPI-naive melanoma', in BRITISH JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, SCOTLAND, Edinburgh, pp. 44 - 44, presented at 15th World Congress on Cancers of the Skin, SCOTLAND, Edinburgh, 03 September 2014 - 06 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342680900098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kefford R; Hamid O; Robert C; Ribas A; Wolchock JD; Hodi FS; Joshua AM; Hwu W-J; Gangadhar TC; Patnaik A; Hersey P; Weber J; Joseph R; Gergich K; Li X; Chun P; Ebbinghaus S; Kang SP; Daud A, 2014, 'Randomized comparison of two doses of the anti-programmed death-1 monoclonal antibody MK-3475 for ipilimumab (IPI)-refractory and IPI-naive melanoma', in BRITISH JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, SCOTLAND, Edinburgh, pp. E56 - E56, presented at 15th World Congress on Cancers of the Skin, SCOTLAND, Edinburgh, 03 September 2014 - 06 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344006900098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ribas A; Hodi FS; Kefford R; Hamid O; Daud A; Wolchok JD; Hwu W-J; Gangadhar TC; Patnaik A; Joshua AM; Hersey P; Weber JS; Dronca RS; Zarour HM; Gergich K; Li XN; Lannone R; Kang SP; Ebbinghaus S; Robert C, 2014, 'Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2014.32.18_suppl.lba9000

Leibowitz-Amit R; Joshua AM; Ezzat S; Bourdeau I; Olney H; Oosting S; Seah J-A; Ruether JD; Chin S; Asa SL; Krzyzanowska MK; Knox JJ, 2014, 'A single-arm, phase II, multicenter trial of sunitinib (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Updated interim results.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e15621

Joseph RW; Elassaiss-Schaap J; Wolchok JD; Joshua AM; Ribas A; Hodi FS; Hamid M; Robert C; Daud A; Hwu W-J; Kefford R; Hersey P; Weber JS; Patnaik A; De Alwis DP; Perrone AM; Kang SP; Ebbinghaus S; Anderson KM; Gangadhar TC, 2014, 'Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.3015

Kefford R; Ribas A; Hamid O; Robert C; Daud A; Wolchok JD; Joshua AM; Hodi FS; Gangedher TC; Hersey P; Weber JS; Dronca RS; Patnaik A; Zarour HM; Dolled-Filhart M; Lunceford J; Emancipator K; Ebbinghaus S; Rang SP; Hwu W-J, 2014, 'Clinical efficacy and correlation with tumor PD-L1 expression in patients (pts) with melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.3005

Alimohamed NS; Leibowitz-Amit R; Templeton AJ; Seah J-A; Vera-Badillo FE; Joshua AM; Knox JJ; Tannock I; Sridhar SS, 2014, 'Do special access programs facilitate off-label prescribing? The experience of enzalutamide in prostate cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.6550

Hamilton RJ; Li J; Naini V; San Kheoh T; De Porre P; Molina A; Lelbowitz-Amit R; De Bono JS; Scher HI; Ryan CJ; Chi KN; Joshua AM, 2014, 'Effect of concomitant medication use on outcomes of ties and placebo arms of the COU-AA-301 and COU-AA-302 studies of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16045

Ribes A; Hodi FS; Kefford R; Hamid O; Daud A; Wolchok JD; Hwu W-J; Gangadhar TC; Patnaik A; Joshua AM; Hersey P; Weber JS; Dronca RS; Zarour HM; Gergich K; Li XN; Iannone R; Kang SP; Ebblnghaus S; Robert C, 2014, 'Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358613201964&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodi FS; Ribes A; Daud A; Hamid O; Robert C; Kefford R; Hwu W-J; Gangadhar TC; Joshua AM; Hersey P; Weber JS; Dronca RS; Perrone AM; Gammage L; Mille D; Xue D; Kang SP; Chun P; Ebbinghaus S; Wolchok JD, 2014, 'Evaluation of immune-related response criteria (irRC) in patients (pis) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.3006

Leibowitz-Amit R; Atenafu EG; Seah J-A; Templeton AJ; Vera-Badillo FE; Alimohamed NS; Knox JJ; Sridhar SS; Tannock I; Joshua AM, 2014, 'Low-dose abiraterone (abi) with food in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre experience.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.5077

Azad A; Lester R; Leibowitz-Amit R; Joshua AM; Heng DYC; Eigl BJ; Chi KN, 2014, 'Population-based analysis of a novel prognostic model for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.5078

Armstrong AJ; Tombal B; Sternberg CN; Higano CS; Rathkopf DE; Loriot Y; Saad F; Joshua AM; De Bono JS; Venner PM; Caries J; Mainwaring PN; Evans CP; Noonberg SB; Mansbach HH; Bhattacharya S; Perabo F; Phung D; Beer TM, 2014, 'Primary, secondary, and quality-of-life endpoint results from PREVAIL, a phase 3 study of enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.5007

Hamid O; Robert C; Ribas A; Wolchok JD; Hodi FS; Kefford R; Joshua AM; Hwu W-J; Gangadhar TC; Patnaik A; Hersey P; Weber JS; Joseph RW; Gergich K; Li XN; Chun P; Ebbinghaus S; Kang SP; Daud A, 2014, 'Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-347 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.3000

Joshua AM; Shore ND; Saad F; Chi KN; Olsson CA; Emmenegger U; Scholz MC; Berry WR; Mukherjee S; Winquist E; Haas NB; Hasabou N; Dmuchowski C; Perabo F; Hirmand M; Foley MA; Rathkopf DE, 2014, 'Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.5051

Efstathiou E; Deshpande H; George D; Joshua AM; Taplin M-E; Griffin TW; Londhe A; Todd M; Molina A, 2014, 'An exploratory analysis of efficacy and safety of abiraterone acetate (AA) in black patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (ctx)', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-CT313

Daud AI; Hamid O; Ribas A; Hodi FS; Hwu W-J; Kefford R; Wolchok J; Hersey P; Weber JS; Joseph R; Gangadhar TC; Dronca RS; Patnaik A; Zarour H; Joshua AM; Gergich K; Wu D; Lunceford JK; Emancipator K; Dolled-Filhart M; Li N; Ebbinghaus S; Kang SP; Robert C, 2014, 'Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-CT104

Tan Q; Joshua A; Saggar JK; Man Y; Lee CCM; Wouters BR; Tannock IF, 2014, 'Pantoprazole enhances the activity of docetaxel chemotherapy for solid tumors by inhibition of autophagy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at AACR Special Conference on Cellular Heterogeneity in the Tumor Microenvironment, CA, San Diego, 26 February 2014 - 01 March 2014, http://dx.doi.org/10.1158/1538-7445.CHTME14-A54

Leibowitz-Amit R; Joshua AM; Ezzat S; Bourdeau I; Olney H; Oosting S; Ruether JD; Chin S; Palmieri C; Seah J-A; Assa SL; Krzyzanowska M; Knox JJ, 2014, 'A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.431

Vera-Badillo FE; Leibowitz-Amit R; Templeton A; Seah J-A; Sridhar SS; Knox JJ; Tannock I; Joshua AM, 2014, 'Clinical activity of enzalutamide against metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on abiraterone acetate: The Princess Margaret experience.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.159

Leibowitz-Amit R; Atenafu EG; Seah J-A; Templeton AJ; Vera-Badillo FE; Solow HL; Knox JJ; Sridhar SS; Tannock I; Joshua AM, 2014, 'Dose-modified abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre (PM) experience', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.61

Beer TM; Armstrong AJ; Sternberg CN; Higano CS; Iversen P; Loriot Y; Rathkopf DE; Bhattacharya S; Carles J; De Bono JS; Evans CP; Joshua AM; Kim C-S; Kimura G; Mainwaring PN; Mansbach HH; Miller K; Noonberg SB; Venner PM; Tombal B, 2014, 'Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.lba1

Seah J-A; Leibowitz-Amit R; Atenafu EG; Alimohamed N; Joshua AM; Knox JJ; Sridhar SS, 2014, 'Evaluation of the neutrophil-lymphocyte ratio (NLR) during neoadjuvant chemotherapy (NC) for muscle-invasive bladder cancer (MIBC) and correlation with pathologic response to treatment', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.351

Seah J-A; Leibowitz-Amit R; Atenafu EG; Alimohamed N; Joshua AM; Knox JJ; Tannock I; Sridhar SS, 2014, 'Neoadjuvant gemcitabine-cisplatin (GC) for muscle-invasive bladder cancer (MIBC): Does midway CT staging predict for pathologic complete response (pCR)?', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.306

Azad A; Lester R; Leibowitz-Amit R; Joshua AM; Heng DYC; Eigl BJ; Chi KN, 2014, 'Population-based analysis of a novel prognostic model for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.29

Hersey P; Ribas A; Hodi FS; Kefford R; Hamid O; Daud A; Wolchok JD; Hwu W-J; Gangadhar TC; Patnaik A; Joshua AM; Weber J; Dronca R; Zarour H; Gergich K; Li X; Iannone R; Kang SP; Ebbinghaus S; Robert C, 2014, 'EFFICACY AND SAFETY OF THE ANTI-PD-1 MONOCLONAL ANTIBODY MK-3475 IN 411 PATIENTS (pts) WITH MELANOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 48 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716500015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dal Pra A; Zannella V; Glicksman R; Sykes J; Muaddi H; Joshua AM; Wouters BG; Milosevic M; Koritzinsky M; Bristow RG, 2013, 'Metformin and Prostate Cancer Radiation Therapy: Improved Outcomes Due to Enhanced Tumor Oxygenation', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, GA, Atlanta, pp. S170 - S170, presented at 55th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), GA, Atlanta, 22 September 2013 - 25 September 2013, http://dx.doi.org/10.1016/j.ijrobp.2013.06.440

Manokumar T; Aziz S; Rizvi F; Breunis H; Joshua AM; Tannock I; Alibhai SMH, 2013, 'A prospective study examining PROs and other geriatric outcomes in older adults with prostate cancer undergoing chemotherapy.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419603038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ribas A; Robert C; Daud A; Hodi FS; Wolchok JD; Kefford R; Patnaik A; Hwu W-J; Weber JS; Joshua A; Hersey P; Gangadhar TC; Joseph RW; Dronca RS; Zarour HM; Ebbinghaus S; Gergich K; Li XN; Kang SP; Hamid O, 2013, 'Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419602710&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Joshua AM; Zannella VE; Downes MR; Bowes B; Koritzinsky M; Sweet J; Trachtenberg J; Jewett MAS; Finelli A; Fleshner NE; Pollak MN, 2013, 'Final results of a phase II study of neoadjuvant metformin in prostatic carcinoma', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601668&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Margel D; Urbach DR; Lipscombe L; Bell C; Kilkarni G; Austin P; Joshua AM; Fleshner NE, 2013, 'Metformin use and all-cause and prostate-cancer-specific mortality among diabetic men', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601608&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hotte SJ; Eisenhauer EA; Joshua AM; Kumar V; Ellard S; Gregg RW; Macfarlane RJ; Winquist E; Torri V; Ruether JD; Basappa NS; Kakumanu AS; North SA; Kollmannsberger CK; Tinker A; Mirchandani D; Tassignon A; Hausman DF; Allan AL; Chi KN, 2013, 'NCIC CTG, IND-205: A phase II study of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer (CRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601640&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leibowitz-Amit R; Templeton AJ; Atenafu EG; Vera-Badillo FE; Chllamma M; Solow HL; Knox JJ; Tannock I; Sridhar SS; Joshua AM, 2013, 'Novel predictive markers of PSA response to abiraterone acetate in men with metastatic castration-resistant-prostate-cancer (mCRPC)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601656&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carvajal RD; Sosman JA; Quevedo F; Milhem MM; Joshua AM; Kudchadkar RR; Linette GP; Gajewski T; Lutzky J; Lawson DH; Lao CD; Flynn PJ; Albertini MR; Sato T; Paucar D; Panageas KS; Dickson MA; Wolchok JD; Chapman PB; Schwartz GK, 2013, 'Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419603135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carvajal RD; Sosman JA; Quevedo F; Milhem MM; Joshua AM; Kudchadkar RR; Linette GP; Gajewski T; Lutzky J; Lawson DH; Lao CD; Flynn PJ; Albertini MR; Sato T; Paucar D; Panageas KS; Dickson MA; Wolchok JD; Chapman PB; Schwartz GK, 2013, 'Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335564000012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tan Q; Joshua A; Saggar J; Yu M; Lee CM; Koritzinsky M; Wouters BR; Tannock IF, 2013, 'Pantoprazole enhances the activity of chemotherapy for solid tumors by inhibition of autophagy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-3829A

Downes MR; Sweet J; Zannella V; Bowes B; Koritzinsky M; Evans AJ; Trachtenberg J; Jewett M; Finelli A; Fleshner N; Pollak M; Joshua AM, 2013, 'The Effects of Metformin on the mTORC Pathway in Prostate Cancer', in LABORATORY INVESTIGATION, NATURE PUBLISHING GROUP, MD, Baltimore, pp. 207A - 207A, presented at 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), MD, Baltimore, 02 March 2013 - 08 March 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000314789301178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Downes MR; Sweet J; Zannella V; Bowes B; Koritzinsky M; Evans AJ; Trachtenberg J; Jewett M; Finelli A; Fleshner N; Pollak M; Joshua AM, 2013, 'The Effects of Metformin on the mTORC Pathway in Prostate Cancer', in MODERN PATHOLOGY, NATURE PUBLISHING GROUP, MD, Baltimore, pp. 207A - 207A, presented at 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), MD, Baltimore, 02 March 2013 - 08 March 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000314444401258&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Templeton A; Wang L; Vera-Badillo F; Attalla M; De Gouveia P; Leibowitz-Amit R; Knox JJ; Moore MJ; Sridhar SS; Joshua AM; Tannock I, 2013, 'From trial to practice: The Princess Margaret Hospital (PMH) experience with docetaxel and prednisone for men with metastatic castration resistant prostate cancer (mCRPC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, presented at Genitourinary Cancers Symposium of the Conquer-Cancer-Foundation of American-Society-of-Clinical-Oncology (ASCO), FL, Orlando, 14 February 2013 - 16 February 2013, http://dx.doi.org/10.1200/jco.2013.31.6_suppl.125

Brade AM; Kim J; Brierley J; Dinniwell R; Wong R; Cho C; Kassam Z; Joshua A; Knox J; Dawson L, 2012, 'Phase I Study of Sorafenib and Whole-liver Radiation Therapy (WLRT) or Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, MA, Boston, pp. S11 - S12, presented at 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), MA, Boston, 28 October 2012 - 31 October 2012, http://dx.doi.org/10.1016/j.ijrobp.2012.07.035


Back to profile page